Brain uptake of intranasally applied radioiodinated leptin in Wistar rats

Endocrinology

Volumn 147, Issue 5, 2006, Pages 2088-2094

  Fliedner, Stephanie ^a   Schulz, Carla ^a   Lehnert, Hendrik ^a,b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL COVENTRY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; RECOMBINANT LEPTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG TRANSPORT; DRUG UPTAKE; ENTORHINAL CORTEX; HYPOTHALAMUS; MALE; NONHUMAN; NOSE; OCCIPITAL CORTEX; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIODINATION; RAT; RAT STRAIN; STATISTICAL SIGNIFICANCE;

ADIPOSE TISSUE; ADMINISTRATION, INTRANASAL; ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CENTRAL NERVOUS SYSTEM; HYPOTHALAMUS; IODINE RADIOISOTOPES; KIDNEY; LEPTIN; MALE; MODELS, STATISTICAL; NEURONS; OBESITY; RATS; RATS, WISTAR; TIME FACTORS; TISSUE DISTRIBUTION; TRICHLOROACETIC ACID;

EID: 33645876805     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-1016     Document Type: Article

References (23)

1. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL 1996 Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292-295
2. Levin BE, Dunn-Meynell AA, Banks WA 2004 Obesity-prone rats have normal blood-brain barrier transport but defective central leptin signaling before obesity onset. Am J Physiol Regul Integr Comp Physiol 286:R143-R150
3. Munzberg H, Myers Jr MG 2005 Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 8:566-570
4. Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV 1996 Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348:159-161
5. Fujioka K, Patane J, Lubina J, Lau D 1999 CSF leptin levels after exogenous administration of recombinant methionyl human leptin. JAMA 282:1517-1518
6. Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M 1999 Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 282:1568-1575
7. Van Heek M, Compton DS, France CF, Tedesco RP, Fawzi AB, Graziano MP, Sybertz EJ, Strader CD, Davis Jr HR 1997 Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J Clin Invest 99:385-390
8. Halaas JL, Boozer C, Blair-West J, Fidahusein N, Denton DA, Friedman JM 1997 Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci USA 94:8878-8883
9. Schulz C, Paulus K, Lehnert H 2004 Central nervous and metabolic effects of intranasally applied leptin. Endocrinology 145:2696-2701
10. Shimizu H, Oh I, Okada S, Mori M 2005 Inhibition of appetite by nasal leptin administration in rats. Int J Obes Relat Metab Disord 29:858-863
11. Kristensson K, Olsson Y 1971 Uptake of exogenous proteins in mouse olfactory cells. Acta Neuropathol (Berl) 19:145-154
12. 125I-NGF to the brain via the olfactory route. Drug Delivery 4:87-92
13. Chen XQ, Fawcett JR, Rahman YE, Ala TA, Frey II WH 1998 Delivery of nerve growth factor to the brain via the olfactory pathway. J Alzheimers Dis 1:35-44
14. Gopinath PG, Gopinath G, Kumar TCA 1978 Target site of intranasally sprayed substances and their transport across the nasal mucosa: a new insight into the intranasal route of drug-delivery. Curr Ther Res 23:596-607
15. Jansson B 2004 Models for the transfer of drugs from the nasal cavity to the central nervous system. PhD thesis, University of Uppsala, Sweden
16. Thorne RG, Pronk GJ, Padmanabhan V, Frey WH 2004 Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127:481-496
17. Banks WA, Kastin AJ, Huang W, Jaspan JB, Maness LM 1996 Leptin enters the brain by a saturable system independent of insulin. Peptides 17:305-311
18. Zlokovic BV, Jovanovic S, Miao W, Samara S, Verma S, Farrell CL 2000 Differential regulation of leptin transport by the choroid plexus and bloodbrain barrier and high affinity transport systems for entry into hypothalamus and across the blood-cerebrospinal fluid barrier. Endocrinology 141:1434-1441
19. Fei H, Okano HJ, Li C, Lee GH, Zhao C, Darnell R, Friedman JM 1997 Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues. Proc Natl Acad Sci USA 94:7001-7005
20. Uotani S, Bjorbaek C, Tornoe J, Flier JS 1999 Functional properties of leptin receptor isoforms: internalization and degradation of leptin and ligand-induced receptor downregulation. Diabetes 48:279-286
21. Cases JA, Gabriely I, Ma XH, Yang XM, Michaeli T, Fleischer N, Rossetti L, Barzilai N 2001 Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo. Diabetes 50:348-352
22. Hedin L, Olsson B, Diczfalusy M, Flyg C, Petersson AS, Rosberg S, Albertsson-Wikland K 1993 Intranasal administration of human growth hormone (hGH) in combination with a membrane permeation enhancer in patients with GH deficiency: a pharmacokinetic study. J Clin Endocrinol Metab 76:962-967
23. Ennis RD, Borden L, Lee WA 1990 The effects of permeation enhancers on the surface morphology of the rat nasal mucosa: a scanning electron microscopy study. Pharm Res 7:468-475